DOI:

At the dawning of interventional cardiology: Andreas Gruentzig, 30 years after <br /> 15 September 1977-15 September 2007

Patrick W. Serruys, Editor-in-Chief

Dear Colleagues,

On the 15th of September 1977, Andreas Gruentzig performed his first angioplasty. Thirty years later, on the 15th of September 2007, three hundred senior interventional cardiologists gathered in that same auditorium where Andreas broadcast live case demonstrations from the cath lab of the University Hospital in Zurich, Switzerland in 1978, 1979 and 1980.

All of us who attended this meeting were profoundly moved to be once again sitting here, on the same seats where we witnessed those live cases in 1978-1980. All of us experienced the same feeling of déjà vu, suddenly appreciating what has been achieved in since. And all of us could see, individually and with deep emotion, our careers passing before us in the blink of an eye, as if those intervening 30 years were nothing more than mere months and not decades. But time does indeed move on, and among those present there were some already enjoying retirement, while the rest of us will soon follow.

When you consider that there are 7.5 million individual patients who have been treated today with drug eluting stents – not even counting all those treated in earlier years by bare metal stents – you begin to understand the depth and lasting impact that this visionary master has had on the personal life of so many. Without any doubt, if Andreas Gruentzig were alive today, he would have been eligible for the Nobel Prize and join fellow giants of cardiology like André Frédéric Cournand, Werner Forssmann or Dickinson W. Richards.

Returning to this 30th anniversary meeting, the attendees were reminded of the luck that must be on your side as an operator, particularly in treating your first case. Adolph Bachmann was a heavy smoker, he spent many days in the CCU with unstable angina before stabilising. During his exercise tests before his treatment, ST elevations were present. Three days after the then successful procedure he still had some residual ST elevation during exercise testing. For some of us, it was the first time we learned about these facts and we were frankly flabbergasted by the luck of patient and operator. And so it is like this that history was written...

Many of us deplored the fact that young interventional cardiologists could not be there with us, participating as well in these two days of presentation and history which reflected the dedication and commitment, but above all the courage, of this first generation of interventional cardiologists.

The sense of comradeship during the two days was overwhelming. The presence of Andreas’s first wife and daughter, as well as so many pioneers of our craft, was exciting, touching and simply breathtaking. This meeting, broadcast on the internet, should be a source of inspiration for the young generation since it’s a complete mixture of ideas, convictions, innovation, linked to an unfailing stubbornness in pursing goals, a sure courage in approaching an infirm fellow man, and the honesty to report acute and late failures. From the very beginning ethics and credibility have been at very the core of this, our endeavour and should always remain there, today and into the future.

Volume 3 Number 3
Nov 20, 2007
Volume 3 Number 3
View full issue


Key metrics

Suggested by Cory

Debate

10.4244/EIJ-E-25-00009 Jun 16, 2025
Guideline recommendations for QFR should be revisited: pros and cons
Fearon W and Biscaglia S

Flashlight

10.4244/EIJ-D-24-00795 Jun 16, 2025
Transcaval transcatheter aortic valve implantation via left-sided venous access
Doyle C and Casserly I

Letter to the editor

10.4244/EIJ-D-25-00325 Jun 16, 2025
Reply: Completeness or complexity? A nuanced reflection on multivessel revascularisation
Laudani C et al
free

Letter to the editor

10.4244/EIJ-D-25-00197 Jun 16, 2025
Letter: Completeness or complexity? A nuanced reflection on multivessel revascularisation
Sticchi A and Biondi-Zoccai G
free

Research Correspondence

10.4244/EIJ-D-24-01048 Jun 16, 2025
Next-day and 48-hour discharge following alternative access for transcatheter aortic valve implantation
Zendo Y et al
Trending articles
310.93

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
172.05

Focus article

10.4244/EIJY19M08_01 Jan 17, 2020
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update
Glikson M et al
free
76.25

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
56.65

Clinical research

10.4244/EIJ-D-20-01155 Oct 20, 2021
A deep learning algorithm for detecting acute myocardial infarction
Liu W et al
free
35

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved